Arkolith/Insider Trading/TLSI/Form 4

Szela Mary T

CEO AND PRESIDENT, DirectorTriSalus Life Sciences, Inc. (TLSI) · full profile →Form 4 · filed Jan 29, 2025
Net Buying
Open-Market Buys
$50K
Open-Market Sells
$0
Net Open-Market Flow
$50K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 28, 2025Buy(P)5K$5.12$24K434K
Jan 27, 2025Buy(P)5K$5.42$26K430K
Jan 27, 2025Grant(A)40K—$0425K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 27, 2025Grant(A)240K—$0240K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-002292) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML